Please use this identifier to cite or link to this item:
https://scholars.lib.ntu.edu.tw/handle/123456789/602262
Title:
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial